Annual report for FDC Ltd. for FY-2018
25-05-2018
Announcement Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
This is to inform you that the Company's Manufacturing facility for Active Pharmaceutical Ingredients (API's), located at Roha - Maharashtra, was recently inspected by US FDA. It has successfully cleared the US FDA GMP inspection with 'No observation'. This was the 12th consecutive successful US FDA inspection of this facility. The Active Pharmaceutical Ingredients (API's) manufactured at the above facility continues to be exported to USA. Kindly take the above on record.05-05-2018
Board to consider Dividend
FDC Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on May 25, 2018 inter alia, to consider and approve the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2018. Further the Board will also inter alia, consider the recommendation of dividend, if any, for the year ended March 31, 2018....03-05-2018
Board Meeting-Closure of Trading Window
In terms of the Code of Conduct adopted by the Company pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window of the Company will remain closed for all the Directors and Designated employees from May 18, 2018 to May 27, 2018 (both days inclusive).03-05-2018
Board Meeting Scheduled To Be Held On Friday, May 25, 2018
This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, May 25, 2018 of the Company at Mumbai, to interalia, consider and approve the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2018. Further the Board will also interalia, consider the recommendation of dividend, if any, for the year ended 31st March, 201803-05-2018
Regulation 40 (9) & 40 (10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
Please find enclosed herewith the Certificate under Regulation 40(9) of the Listing Regulations dated April 20, 2018 received from Sanjay Dholakia & Associates, Company Secretaries in Practice for the six months ended March 31, 201820-04-2018
Shareholding for the Period Ended March 31, 2018
FDC Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click here20-04-2018
Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Varsharani KatreDesignation :- Company Secretary and Compliance Officer12-04-2018
Pursuant To Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, Compliance Certificate For The Half Year Ended On 31-03-2018
This is to certify that pursuant to Regulation 7 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we have complied with the requirements pursuant to Regulation 7 (2) by ensuring that all the activities in relation to both, Physical and Electronic, share transfer facilities i.e. Dematerlization and Rematerlization are maintained through our Registrar and Share Transfer Agent, M/s. Sharex Dynamic (India) Pvt. Ltd.,...10-04-2018